MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
MTBC General and Administrative Expenses 2011-2026 | MTBC
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses MTBC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.4 M | 16.1 M | 21.5 M | 23.8 M | 24.3 M | 22.8 M | 17.9 M | 16.3 M | 11.7 M | 12.5 M | 12 M | 9.94 M | 4.74 M | 4.4 M | 3.83 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.3 M | 3.83 M | 14.7 M |
Quarterly General and Administrative Expenses MTBC
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.5 M | 4.89 M | 4.36 M | 4.33 M | - | 4.38 M | 4.03 M | 3.72 M | - | 5.48 M | 5.92 M | 5.12 M | - | 6.5 M | 6.39 M | 5.58 M | - | 5.92 M | 6.27 M | 5.62 M | - | 6.19 M | 5.39 M | 5.59 M | - | 4.45 M | 5.14 M | 4.16 M | - | 5.13 M | 3.05 M | 2.6 M | - | 2.47 M | 2.77 M | 2.99 M | - | 2.57 M | 2.69 M | 2.91 M | - | 3.09 M | 3.18 M | 3.14 M | - | 3.71 M | 1.45 M | 1.29 M | - | 1.36 M | 1.22 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.5 M | 1.22 M | 4.12 M |
General and Administrative Expenses of other stocks in the Health information services industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Evolent Health
EVH
|
304 M | $ 4.18 | -2.11 % | $ 477 M |  USA |
 |
Accolade
ACCD
|
31.6 M | - | 0.29 % | $ 206 M | USA |
 |
Cerner Corporation
CERN
|
521 M | - | - | $ 27.9 B | USA |
 |
Change Healthcare
CHNG
|
687 M | - | - | $ 9.03 B | USA |
 |
Computer Programs and Systems
CPSI
|
76.2 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
881 M | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
25.7 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
123 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
217 M | - | - | $ 6.37 B | USA |
 |
HealthEquity
HQY
|
120 M | $ 84.84 | 1.01 % | $ 7.31 B | USA |
 |
iCAD
ICAD
|
7.63 M | - | - | $ 102 M | USA |
 |
GoodRx Holdings
GDRX
|
114 M | $ 2.92 | 2.82 % | $ 1.04 B | USA |
 |
Akerna Corp.
KERN
|
33.4 M | - | - | $ 161 M | USA |
 |
10x Genomics
TXG
|
343 M | $ 21.6 | -3.66 % | $ 2.53 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
314 M | - | -10.39 % | $ 886 M | USA |
 |
1Life Healthcare
ONEM
|
323 M | - | - | $ 3.37 B | USA |
 |
NextGen Healthcare
NXGN
|
181 M | - | - | $ 1.6 B | USA |
 |
Premier
PINC
|
701 M | - | - | $ 2.33 B | USA |
 |
Health Catalyst
HCAT
|
49.6 M | $ 1.52 | -4.4 % | $ 106 M | USA |
 |
OptimizeRx Corporation
OPRX
|
776 K | $ 6.44 | -2.87 % | $ 110 M | USA |
 |
Schrödinger
SDGR
|
95.4 M | $ 13.13 | -1.13 % | $ 964 M | USA |
 |
Phreesia
PHR
|
79.9 M | $ 10.17 | 3.41 % | $ 608 M | USA |
 |
R1 RCM
RCM
|
120 M | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
432 M | $ 7.25 | 4.17 % | $ 1.28 B | USA |
 |
Signify Health
SGFY
|
202 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
11.7 M | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
62.5 M | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
853 K | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
88 M | $ 7.97 | 4.32 % | $ 128 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
75 M | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
32.8 M | $ 23.96 | 1.78 % | $ 719 M | USA |
 |
Omnicell
OMCL
|
410 M | $ 43.82 | 1.13 % | $ 2.01 B | USA |
 |
Progyny
PGNY
|
32 M | $ 23.72 | 23.8 % | $ 2.04 B | USA |
 |
So-Young International
SY
|
252 M | $ 2.97 | -1.66 % | $ 231 M |  China |
 |
Veeva Systems
VEEV
|
301 M | $ 166.34 | -1.14 % | $ 27.2 B | USA |
 |
Zhongchao
ZCMD
|
9.81 M | $ 1.58 | -25.82 % | $ 5.4 M | China |